Daiichi all news related to

Astra to pay Daiichi up to $6 billion for new cancer drug

July 27, 2020

AstraZeneca agreed to pay as much as $6 billion to buy into Daiichi Sankyo Co.'s promising medicine for lung and breast cancer, the drugmakers' second potential blockbuster oncology deal in two years.

All News Daiichi In Focus Daiichi BreakingNews of Daiichi Your Interested Follow Story Daiichi

Astra to pay Daiichi up to $6 billion for new cancer drug